The antibody-drug conjugate trastuzumab deruxtecan, or T-DXd, is an effective first-line treatment in patients with HER2-low metastatic breast cancer, conferring an additional 5 months’ progression-free survival […]

CHICAGO — Tumor debulking does not improve survival in multiorgan metastatic colorectal cancer (CRC), according to a phase 3 trial presented at the American Society of […]

BOSTON — Men who stop using performance-enhancing anabolic-androgenic steroids (AAS) experience significant depression, anxiety, and diminished sexual function within the first year after quitting, new research […]

Three different definitions of nonanemic iron deficiency (ID), a common disorder causing substantial morbidity in women, were significantly associated with different population prevalence estimates, a data […]

MILAN — Seladelpar, an investigational selective peroxisome proliferator-activated receptor delta agonist, achieves both biochemical and clinically meaningful improvements in pruritus and liver injury in patients with […]

Novel, noninvasive testing is able to predict dementia onset with 80% accuracy up to 9 years before clinical diagnosis. The results suggest resting-state functional MRI (rs-fMRI) […]

HOUSTON, Texas — Obstructive sleep apnea (OSA) not only affects the patient’s health but also disrupts their partner’s sleep, which can put strain on a relationship.  […]

June 10, 2024 — Prostate cancer has a huge impact on men. It’s the second most common cancer after skin cancer (an estimated 290,00 cases will […]